GET THE APP
National Cancer Institute (NCI)- Cairo
National Cancer Institute (NCI)- Cairo was established during the 1950s and was implemented through the great administrative efforts of Professor Ahmed Lotfi Abou El Nassr. With the same enthusiasm, Professor Ismail El Sebai introduced radical surgery for cancer and trained a large group of Egyptian surgeons. Thanks to their efforts, Oncology was recognized as a separate specialty by Cairo University in 1959. It included a hospital with 270 beds which was built in the sixties and started operating in 1969. Manpower Included 40 medical staff members as well as, 150 supporting and nursing staff serving in first year of operation about 5,700 new cases and 8,000 outpatient visits. NCI wishes to control of cancer in Egypt through developing and maintaining integrated quality programs in patient care, research, education and prevention. They are committed to the multidisciplinary approach in cancer management in which different treatment modalities cooperate rather then compete. Professional and public educations are vital to solve the problem of the late presentation of patients. NCI hospital of 550 beds developed in stages. It is now the largest cancer hospital in the Middle East. This project received valuable support from USAID program of the American government, the European Union, and the United Nations Development Program (UNDP). NCI-Cairo was accepted into the UICC as full member in 1973.
Background and History
IRB of the Egyptian National Cancer Institute was established in 1997. It was composed of 5 members including both genders, non-affiliated and non-medical members. The load of review was small and was mostly pharmaceutically sponsored studies. Later the local researchers of the National Cancer institute subjected their proposals for review and approval. The IRB also reviews research studies from other educational centres that lacking this service. In 2004, the NCI IRB signatory official got registered at US Department of Health & Human Services (Organization No. IORG0003381, IRB No. IRB00004025, Federal Wide Assurance (FWA) No. FWA00007284. The number of submitted research studies increased progressively through the years and members of the IRB also increased to cope with the increased work load. In 2009, the Vice Dean of the NCI issued an Act that mandates IRB approval for all MSc and MD thesis.
The primary mission of the Institutional Review Board (IRB) is to protect the rights, welfare and privacy of all individuals participating in biomedical, social, and behavioral research activities, including field or off-site research, as conducted by NCI-Egypt faculty, staff and students. The IRB conducts reviews of proposed research studies employing an assessment process that determines that the methodology used is consistent with sound research design and that the risk to participants/subjects is minimized. The IRB also provides interpretive assistance and support to the research community.
Institutional Review Board (IRB)
Dr. Ahmed Morsi Mostafa, MD, Vice Dean for Research and Post-graduate Education, Professor of Surgical Oncology
Dr. Atef Badran, MSc, PhD, Senior Clinical Data Manager and IRB Designee IRB secretary
Mr. Ahmed A. Hamid, Diploma in Computer Science